www.fdanews.com/articles/122174-gsk-signs-on-astex-in-partnership-for-about-33-million

GSK Signs on Astex in Partnership for About $33 Million

November 13, 2009

GlaxoSmithKline (GSK) has inked a deal with Astex Therapeutics to discover, develop, and commercialize compounds directed against multiple targets for £20 million (about $33 million) up front.
Genetic Engineering & Biotechnology News